Viewing Study NCT00132067


Ignite Creation Date: 2025-12-25 @ 12:52 AM
Ignite Modification Date: 2026-01-01 @ 7:52 AM
Study NCT ID: NCT00132067
Status: COMPLETED
Last Update Posted: 2019-07-23
First Post: 2005-08-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Peritoneal Cavity Cancer View
None Recurrent Ovarian Epithelial Cancer View
Keywords: